The polymorphism (-600 C>A) of CpG methylation site at the promoter region of CYP17A1 and its association of male infertility and testosterone levels

Gene

Volumn 534, Issue 1, 2014, Pages 107-112

  Park, Jung Hoon ^a   Lee, Jinu ^b   Kim, Cheol Hee ^c   Lee, Suman ^a  

^a CHA University   (South Korea)

^b Yonsei University   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Androgen; B LCLs; CYP17A1; GAPDH; Male infertility; OAT; PBMCs; SNP; Sperm parameters; Testosterone

Indexed keywords

CYTOCHROME P450 1A; RNA; TESTOSTERONE;

ADRENAL GLAND; ARTICLE; AZOOSPERMIA; B LYMPHOCYTE; CASE CONTROL STUDY; COLON; CONTROLLED STUDY; CPG ISLAND; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; KIDNEY; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH; TESTIS;

EID: 84888021978     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.088     Document Type: Article

References (28)

1. Aban M., Arslan M., Tok E., Tekes S., Budak T., Altintas A. CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer. Int. J. Gynecol. Cancer 2006, 16(Suppl. 1):448-451.
2. Auchus R.J. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol. Metab. Clin. North Am. 2001, 30:101-119. (vii).
3. Barros S.P., Offenbacher S. Epigenetics: connecting environment and genotype to phenotype and disease. J. Dent. Res. 2009, 88:400-408.
4. Bergman-Jungestrom M., Gentile M., Lundin A.C., Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int. J. Cancer 1999, 84:350-353.
5. Bricaire H., et al. A new male pseudo-hermaphroditism associated with hypertension due to a block of 17-hydroxylation. J. Clin. Endocrinol. Metab. 1972, 35:67-72.
6. Carey A.H., et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet. 1994, 3:1873-1876.
7. Chacko P., Rajan B., Mathew B.S., Joseph T., Pillai M.R. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. Breast Cancer 2004, 11:380-388.
8. Hall P.F. Steroidogenic cytochromes P450: do the properties of the homogeneous enzymes reveal important aspects of the regulation of steroid synthesis in vivo?. Endocr. Res. 1984, 10:311-317.
9. Henderson B.E., Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 2000, 21:427-433.
10. Hsieh Y.Y., Chang C.C., Tsai F.J., Lin C.C., Tsai C.H. Cytochrome P450c17alpha 5'-untranslated region *T/C polymorphism in endometriosis. J. Genet. 2004, 83:189-192.
11. Jabara S., et al. 3rd Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J. Clin. Endocrinol. Metab. 2003, 88:484-492.
12. Kamrath C., Hartmann M.F., Remer T., Wudy S.A. The activities of 5alpha-reductase and 17,20-lyase determine the direction through androgen synthesis pathways in patients with 21-hydroxylase deficiency. Steroids 2012, 77:1391-1397.
13. Kater C.E., Biglieri E.G. Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol. Metab. Clin. North Am. 1994, 23:341-357.
14. Kruger T.F., et al. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil. Steril. 1986, 46:1118-1123.
15. Latil A.G., et al. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer 2001, 92:1130-1137.
16. Liu Y., Yao Z.X., Papadopoulos V. Cytochrome P450 17alpha hydroxylase/17,20 lyase (CYP17) function in cholesterol biosynthesis: identification of squalene monooxygenase (epoxidase) activity associated with CYP17 in Leydig cells. Mol. Endocrinol. 2005, 19:1918-1931.
17. Liu Y., Dettin L., Folmer J., Zirkin B., Papadopoulos V. Abnormal Morphology of Spermatozoa in Cytochrome P450 17{alpha}-hydroxylase/17, 20-lyase (CYP17) Deficient Mice. J. Androl. 2007, 28:453-460.
18. Livak K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet. Anal. 1999, 14:143-149.
19. Majumdar S.S., Sarda K., Bhattacharya I., Plant T.M. Insufficient androgen and FSH signaling may be responsible for the azoospermia of the infantile primate testes despite exposure to an adult-like hormonal milieu. Hum. Reprod. 2012, 27:2515-2525.
20. Martinez-Arguelles D.B., Papadopoulos V. Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action. Steroids 2010, 75:467-476.
21. Matsumoto T., Takeyama K., Sato T., Kato S. Androgen receptor functions from reverse genetic models. J. Steroid Biochem. Mol. Biol. 2003, 85:95-99.
22. Miller W.L. Androgen biosynthesis from cholesterol to DHEA. Mol. Cell. Endocrinol. 2002, 198:7-14.
23. New M.I. Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J. Clin. Invest. 1970, 49:1930-1941.
24. Park J.H., et al. Wp specific methylation of highly proliferated LCLs. Biochem. Biophys. Res. Commun. 2007, 358:513-520.
25. Simoni M., et al. Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int. J. Androl. 1999, 22:292-299.
26. World Health Organization WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction 1999, Cambridge University Press, Cambridge, UK. 4th ed.
27. Wilson J.D., Leihy M.W., Shaw G., Renfree M.B. Androgen physiology: unsolved problems at the millennium. Mol. Cell. Endocrinol. 2002, 198:1-5.
28. Yanase T. 17 alpha-Hydroxylase/17,20-lyase defects. J. Steroid Biochem. Mol. Biol. 1995, 53:153-157.